Merck & CompanyvsNu Skin Enterprises

MRK and NUS stock compared: price, dividend, valuation and results, from SEC filings.

MRK

Merck & Company, Inc.

$144.46

Value $357B

-2.23%
MRK's page

NUS

Nu Skin Enterprises, Inc.

$3.93

Value $189M

-2.48%
NUS's page

Merck & Company (MRK) has a market value of $357B and Nu Skin Enterprises (NUS) $189M. Over the last year, with dividends, MRK moved +60.0% and NUS -57.7%. Dividend yield: MRK 2.35%, NUS 6.14%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    MRK$357B

    NUS$189M

    MRK is 1,888 times NUS

  • Revenue, 12 months

    MRK$67.4B

    NUS$1.3B

    MRK is 51 times NUS

  • Net income, 12 months

    MRK$2.5B

    NUS-$234M

  • Operating margin

    MRK–

    NUS-2.0%

  • ROIC

    MRK3.9%

    NUS-2.3%

    6.2 points apart

  • P/E

    MRK145.6

    NUS–

  • Dividend yield

    MRK2.4%

    NUS6.1%

    3.7 points apart

  • 5-year return

    MRK+101.1%

    NUS-89.9%

    191.0 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

MRK+101.1%

NUS-89.9%

010020020222023202420252026
Returns by period
PeriodMRKWith dividendsNUSWith dividends
1 year since November 14, 2025+60.0%Price +55.5%-57.7%Price -59.1%
3 years since November 16, 2023+55.2%+15.8% a yearPrice +41.6%-75.5%-37.4% a yearPrice -77.9%
5 years since November 15, 2021+101.1%+15.0% a yearPrice +72.6%-89.9%-36.7% a yearPrice -91.6%
10 years since November 16, 2016+228.0%+12.6% a yearPrice +141.7%-90.0%-20.6% a yearPrice -92.8%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

MRKMerck & CompanyNUSNu Skin Enterprises

Valuation

MRKNUS
Valuation
Price$144.46$3.93
Market value$357B$189M
Enterprise value (EV)$401B$234M
P/E145.6–
P/E, 5-year median14.817.7
P/B8.00.4
EV/EBIT84.3–
Free cash flow yield4.1%–

Results and growth

MRKNUS
Results and growth
Revenue, 12 months$67.4B$1.3B
Net income, 12 months$2.5B-$234M
Free cash flow, 12 months$14.7B-$26M
Earnings per share, 12 months$0.98-$4.85
Revenue growth, year on year1.3%-14.3%
Revenue growth a year, past+9.4%over 5 years-10.5%over 5 years
EPS growth a year, past+21.2%over 5 years-2.6%over 5 years

Margins and returns on capital

MRKNUS
Margins and returns on capital
Gross margin71.8%67.8%
Operating margin–-2.0%
Net margin3.6%-17.7%
ROIC3.9%-2.3%
ROE5.2%-33.6%

Balance sheet

MRKNUS
Balance sheet
Cash$9.7B$167M
Total debt$53.8B$277M
Net debt / EBITDA5.71.8
Interest cover2.4×-1.8×

Dividends and buybacks

MRKNUS
Dividends and buybacks
Dividend yield2.4%6.1%
Dividend per share, 12 months$3.40$0.24
Dividend growth a year, past+5.8%over 5 years–
Buyback yield1.4%10.6%
Shareholder yield3.8%16.7%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: MRK or NUS

Didn't find what you were looking for?

Ask us
Which is bigger, Merck & Company or Nu Skin Enterprises?

By market value, Merck & Company ($357B) is about 1,888.4 times Nu Skin Enterprises ($189M), at today's prices.

How did MRK and NUS stock do over the last 10 years?

Since November 16, 2016, MRK's price moved +141.7% and NUS's -92.8%. With dividends: MRK +228.0% (+12.6% a year), NUS -90.0% (-20.6% a year). Past returns do not predict future ones.

Which pays the higher dividend, MRK or NUS?

The dividend yield at today's price is 2.35% for Merck & Company and 6.14% for Nu Skin Enterprises. Over the last twelve months they paid $3.40 and $0.24 per share.

Which has the higher profit margins, Merck & Company or Nu Skin Enterprises?

Over the last twelve months, the net margin was 3.6% for Merck & Company and -17.7% for Nu Skin Enterprises, and the operating margin – and -2.0%. Revenue was $67.4B and $1.3B.

Which is the better investment, Merck & Company or Nu Skin Enterprises?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.